Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Journal of Managed Care Pharmacy : JMCP|April 5, 2005
Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settingsJosephine A Mauskopf, Clark Paramore, Won Chan Lee, et al.Medical Care|April 1, 1995
Estimating the value of a generic quality-of-life measureJ A Mauskopf, R Austin, L P Dix, et al.Pharmacoeconomics|April 13, 2002
A Monte Carlo simulation for modelling outcomes of AIDS treatment regimensAnke Richter, Brett Hauber, Kit Simpson, et al.The Journal of Clinical Psychiatry|October 3, 1999
Annual health outcomes and treatment costs for schizophrenia populationsJ A Mauskopf, K David, D L Grainger, et al.Pharmacoeconomics|February 6, 1998
The role of cost-consequence analysis in healthcare decision-makingJ A Mauskopf, J E Paul, D M Grant, et al.Journal of Medical Economics|July 9, 2010
Cost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidenceJosephine A Mauskopf, Christine L Baker, Brigitta U Monz, et al.World Journal of Surgical Oncology|July 10, 2012
Immunonutrition for patients undergoing elective surgery for gastrointestinal cancer: impact on hospital costsJosephine A Mauskopf, Sean D Candrilli, Hélène Chevrou-Séverac, et al.Medical Care|September 1, 1996
Estimating the dollar value of health outcomes from drug-abuse interventionsM T French, J A Mauskopf, J L Teague, et al.The Western Journal of Medicine|September 1, 1995
Beyond the freedom to choose. Medicaid, managed care, and family planningS Rosenbaum, P Shin, A Mauskopf, et al.Depression and Anxiety|October 4, 2008
Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorderJosephine A Mauskopf, Gregory E Simon, Anupama Kalsekar, et al.Pageof 5